Financial Calendar

Siete in: HomeFinancial Calendar

The examination and publication dates of economic and financial results

22Feb2022

Preliminary financial data as at December 31st, 2021 and Guidance 2022

Meeting of the Board of Directors for approval of preliminary financial data as at December 31st, 2021 and Guidance 2022.

24Mar2022

Approval of the Draft Financial Statements at December 31st 2021

Meeting of the Board of Directors to approve the draft Financial Statements at December 31st, 2021.

29Apr2022

Shareholders’ Meeting

Shareholders' Meeting to approve the Financial Statements at December 31st , 2021

11May2022

Quarterly Report at March 31st, 2022

Meeting of the Board of Directors to approve the selected information indicative of the performance of the business for the first quarter of 2022(*) (Production value; EBITDA; Backlog; Net Financial Position) and the related press release containing the quarterly information. (*) Information not subject to revision, not even limited

04Aug2022

Preliminary financial data as at June 30th, 2022

Meeting of the Board of Directors for approval of preliminary financial data at June 30th, 2022.

13Sep2022

Half-Year Financial Statements at June 30th, 2022

Board of Directors for the approval of Half-Year Financial Statements at June 30th, 2022.

10Nov2022

Quarterly Report at September 30th, 2022

Meeting of the Board of Directors to approve the selected information indicative of the performance of the business for the third quarter of 2022(*) (Production value; EBITDA; Backlog; Net Financial Position) and the related press release containing the quarterly information. (*) Information not subject to revision, not even limited.

15Sep2021

Half-Year Financial Statements at June 30th, 2021

Board of Directors for the approval of Half-Year Financial Statements at June 30th, 2021.

15Nov2021

Quarterly Report at September 30th, 2021

Board of Directors for the approval of the press release containing a quarterly reporting with selected information reflective of the development of the business related to the third quarter of 2021(*) (Production Value; EBITDA; Backlog; Net Financial Position). (*) Information not subject to revision, not even limited.